Ignite Creation Date:
2025-12-26 @ 11:09 AM
Ignite Modification Date:
2025-12-31 @ 1:04 PM
Study NCT ID:
NCT06769412
Status:
COMPLETED
Last Update Posted:
2025-10-29
First Post:
2024-12-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Real-World Evidence Study for the Incidence of Retinal Vasculitis (RV) Among Adult Patients Receiving Aflibercept 2 mg in the United States (US)
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-09-01
Completion Date Type:
ACTUAL
First Submit Date:
2024-12-24
First Submit QC Date:
None
Study First Post Date:
2025-01-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-27
Last Update Post Date:
2025-10-29
Last Update Post Date Type:
ESTIMATED